- MEDIUM
- Research
- Tier 1
- Peer-Reviewed Research
Plasmonic photoenzymatic therapy with SERS monitoring for oral cancer
- Source
- Journal of Dental Research (JDR)
- Author
- M. Zhao, H. Shi, W. Jiang, L. Wang, S. Wen, S. Bao, K. Hu, R. Shi, W. Song
- Originally at
- journals.sagepub.com(opens in a new tab)
Summary and scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol. Not the original publisher.
Why it matters for dental
Oral cancer researchers describe a new photoenzymatic therapy approach that pairs plasmonic nanoparticles with surface-enhanced Raman scattering (SERS) monitoring; oral surgeons, oncologists, and academic clinicians may track future clinical translation.
Key points
- 01
Title states that the therapy targets oral squamous cell carcinoma (OSCC).
- 02
Content notes that current photodynamic, chemodynamic, and photothermal therapies face oxygen dependence, insufficient endogenous H2O2, and nonspecific thermal effects.
- 03
Article presents plasmonic photoenzymatic therapy with SERS monitoring as an alternative under investigation.
- 04
Source is ahead-of-print in the Journal of Dental Research and does not report clinical outcomes or timelines.
Who should care
- Specialist
- Academia / research
Read the original
Journal of Dental Research (JDR)
Full reporting and any paywalled content live on journals.sagepub.com. We summarize and score; we do not republish.